Upgrade to SI Premium - Free Trial

CME Group (CME) PT Lowered to $270 at Barclays

July 9, 2026 4:59 AM
Barclays analyst Benjamin Budish lowered the price target on CME Group (NASDAQ: CME) to $270.00 (from $316.00) while maintaining a Equalweight rating.

Categories

Analyst PT Change